Ropes & Gray Advised Eli Lilly in Acquisition of AtaiBeckley to Advance Therapies for Treatment-Resistant Depression and Other Mental Health Conditions Valued Up to $3.8 Billion
July 17, 2026
July 17, 2026
BOSTON, Massachusetts, July 17 -- Ropes and Gray, a law firm, issued the following news:
* * *
Ropes & Gray Advised Eli Lilly in Acquisition of AtaiBeckley to Advance Therapies for Treatment-Resistant Depression and Other Mental Health Conditions Valued Up to $3.8 Billion
Ropes & Gray represented Eli Lilly and Company in an agreement to acquire AtaiBeckley Inc. (NASDAQ: ATAI), a clinical-stage biopharmaceutical company developing innovative therapeu . . .
* * *
Ropes & Gray Advised Eli Lilly in Acquisition of AtaiBeckley to Advance Therapies for Treatment-Resistant Depression and Other Mental Health Conditions Valued Up to $3.8 Billion
Ropes & Gray represented Eli Lilly and Company in an agreement to acquire AtaiBeckley Inc. (NASDAQ: ATAI), a clinical-stage biopharmaceutical company developing innovative therapeu . . .
